申请人:AMGEN INC.
公开号:US20140350244A1
公开(公告)日:2014-11-27
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4-mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives.
本发明提供了在治疗CDK4介导的疾病,如癌症中有用的化合物、制药组合物和方法。所述化合物为融合的吡啶、嘧啶和三嗪衍生物。